Empathogens

Terran Biosciences Seals Deal With France's Pierre Fabre Pharmaceutical

New York-based biotech Terran Biosciences has signed an agreement with French pharmaceutical company Pierre Fabre Médicament for worldwide exclusive rights to develop and commercialize a list of the latter's assets targeting neuropsychiatric conditions.

Terran Biosciences' Four Patent Applications Cover Improved Versions Of Classic Empathogens

Terran Biosciences, the NY-based biotech platform that develops transformational therapeutics announced the publication of four international PCT patent applications covering novel compounds and potentially improved versions of the empathogens methylone (also called bk-MDMA or MDMC), e